AMBRISENTAN Devatis cpr pell 10 mg 30 pce
7680677990045
CH-67799
C02KX02
02.07.1.
Active substances:
Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 6779902
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- Filmtablette: ambrisentanum 10 mg, lactosum monohydricum 141.45 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 374 µg, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, lecithinum ex soja, E 171, E 129 354 µg, pro compresso obducto.
Articles (1)
Ambrisentan Devatis 10 mg, Filmtabletten
Filmtabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ambrisentanum
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum monohydricum
|
141.45 MG | Substance | HBESI |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
natrium
|
374.0 UG | Substance | HBESI |
|
magnesii stearas
|
- | Substance | HNIDK |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
lecithinum ex soja
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 129
|
354.0 UG | Substance | HBESI |
Reimbursement information
Public price
CHF 898.75
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/11/2021
Authorization holder
Devatis AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 67799
- Drug name
- Ambrisentan Devatis, Filmtabletten
- Galenic form
- FILM
- ATC Code
- C02KX02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/10/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 02.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AMBRISENTAN Devatis cpr pell 10 mg 30 pce
- Description (DE)
- AMBRISENTAN Devatis Filmtabl 10 mg 30 Stk
- Market launch
- 29/10/2020
- Narcotic (BTM)
- No